Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
King's College London
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DSM-IV diagnosis of schizophrenia or schizoaffective disorder
Treatment with stable doses of antipsychotic medications. For the purpose of this study stability is defined as a not more than 50% change in the dose of their antipsychotic medication 3 months preceding the screening visit.
Age between 18 and 55 years
Written and witnessed informed consent
Participants must read and write in English at a level sufficient to understand and complete study-related procedures
You may not be if
DSM-IV diagnosis of alcohol or drug dependence in the 6 months, current treatment with benzodiazepines or hypnotics
Current or past skin disease
History of a neurological disorder or a systemic illness with known neurological complications; including epilepsy
History of seizures
Head injury, accompanied with loss of consciousness or/and required hospitalization
Unwillingness or inability to follow or comply with the procedures outlined in the protocol
Clareo Health | Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation
